Equity Details
Price & Market Data
Price: $1.77
Daily Change: -$0.01 / 0.56%
Daily Range: $1.76 - $1.82
Market Cap: $204,697,856
Daily Volume: 801,030
Performance Metrics
1 Week: -5.26%
1 Month: -30.77%
3 Months: -44.79%
6 Months: -56.73%
1 Year: 92.12%
YTD: -57.04%
About NovaBridge Biosciences (NBP)
Analyze the market position of NovaBridge Biosciences (NBP). With a current price of 1.77, the stock exhibits a -$0.01 / 0.56% daily trend. A market capitalization of 204,697,856 indicates its scale. Discover its performance over 1-month (-30.77%) and 3-month (-44.79%) periods.
Company Details
Employees: 30
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2 bispecific antibody, which is in phase 2 clinical trial combination with nivolumab and chemotherapy for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies; Phase 1b clinical trial in combination with nivolumab and chemotherapy in first-line gastric cancer. The company also develops VIS-101, VEGF-A × ANG-2 bispecific biologics in Phase 2 clinical trial to treat wet age-related macular degeneration and other retinal diseases, including diabetic macular edema; ragistomag, which is in Phase 1clinical trial for multiple solid tumors. It has a licensing agreement with AskGene to develop and commercialize VIS-101; collaborations with Bristol Myers Squibb for the development of givastomig; and license and collaboration agreement with AbbVie Ireland Unlimited Company for the development and commercialization of lemzoparlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.